| Control group Mean ± SE (min- max) | Stages of MMVD group Mean ± SE (min- max) | |||
---|---|---|---|---|---|
B1 | B2 | C | D | ||
Heart rate (bpm) | 126.33±4.96a (104-140) | 127.64 ± 3.75 a (108-160) | 129.17 ± 4.90a (120-150) | 158.50 ± 7.45b (146-180) | 163.33 ± 6.00b (155-175) |
Murmur intensity | No | No / < 3/6 | ≥3/6 | > 3/6 | > 3/6 |
LA:AO ratio | 1.27 ± 0.02 a (1.20-1.37) | 1.30 ± 0.04a (1.06-1.5) | 1.67 ± 0.03b (1.6-1.8) | 2.07 ± 0.21c (1.7-2.68) | 2.46 ± 0.13 d (2.2-2.60) |
LVIDd (mm) | 19.96 ± 0.92 a (18-23) | 25.24 ± 2.28 a (16-41) | 28.17 ± 1.88a (21-33) | 31.20 ± 2.73 a (27-39) | 44.20 ± 13.11b (30-70) |
LVIDdN (cm/kg0.294) | 1.09 ± 0.04 a (1.03-1.22) | 1.31 ± 0.07 b (0.76-1.56) | 1.59 ± 0.09 b (1.35-1.90) | 1.76 ± 0.15 c (1.49-2.22) | 2.52 ± 0.7 c (1.77-3.97) |
VHS | 9.7 ± 0.18 a (9.4-10.3) | 9.99 ± 0.1a (9.5-10.5) | 10.10 ± 0.07 a (9.9-10.4) | 11.2 ± 0.27 b (10.8-12) | 11.53 ± 0.14 b (11.3-11.8) |
Radiographic evidence of pulmonary infiltrates | No | No | No | Yes | Yes |